The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function

التفاصيل البيبلوغرافية
العنوان: The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function
المؤلفون: Keith Wesnes, Brian R. Leaker, John F. Golding
المصدر: British Journal of Clinical Pharmacology. 84:1535-1543
بيانات النشر: Wiley, 2018.
سنة النشر: 2018
مصطلحات موضوعية: 0301 basic medicine, Pharmacology, business.industry, Hydrobromide, Antagonist, Muscarinic acetylcholine receptor M3, medicine.disease, Placebo, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Motion sickness, Muscarinic acetylcholine receptor, Darifenacin, Medicine, Pharmacology (medical), business, Oxybutynin, 030217 neurology & neurosurgery, medicine.drug
الوصف: Aims: The aim of this study was to compare the effects of the selective M3 muscarinic acetylcholine receptor antagonist Darifenacin, oral Hyoscine hydrobromide and Placebo on motion sickness induced by cross-coupled stimulation. Methods: The effects of Darifenacin 10 mg or 20 mg, Hyoscine hydrobromide 0.6 mg and Placebo were assessed in a randomised, double-blind, 4-way cross over trial of 16 healthy subjects. Motion sickness, skin conductance (a measure of sweating) and psychomotor cognitive function tests were investigated. Results: Hyoscine hydrobromide produced significantly increased tolerance to motion versus Placebo (P
تدمد: 0306-5251
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b2f1af4ff2db6a45b403dd34a1f6fbf1Test
https://doi.org/10.1111/bcp.13579Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........b2f1af4ff2db6a45b403dd34a1f6fbf1
قاعدة البيانات: OpenAIRE